Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

Discussion
1

Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2 , a rapid molecular diagnostic test for qualitative detection of SARS-CoV-2 , the virus causing COVID-19. The test has been designed to operate on any of Cepheid’s more than 23,000 automated GeneXpert® Systems worldwide, with a detection time of approximately 45 minutes.

http://cepheid.mediaroom.com/2020-03-21-Cepheid-Receives-Emergency-Use-Authorization-from-FDA-for-Rapid-SARS-CoV-2-Test

1 Like
2

See article in STAT about the Cepheid test for COVID-19:

New coronavirus test returns results in 45 minutes, but it may be limited to hospitals

3

This will be very benefecial, and in shorter TAT we cn get results. When can we expect kits in market.

4

Do you know the cost For each cartridge?

5

http://www.stoptb.org/news/stories/2020/ns20_012.html